Carl Sandler Biography and Net Worth



Carl Sandler serves as Independent Director of the Company. Mr. Sandler has built numerous consumer-facing technology and healthcare brands. He was the CEO of Enochian BioPharma, Inc. prior to its acquisition by the Registrant and has been the Manager of Weird Science, LLC since March of 2017. Mr. Sandler is a widely respected thought leader, journalist and speaker on issues related to public health, HIV/AIDS, sex and sexuality. He has spoken extensively at HIV/AIDS conferences worldwide about innovative uses of technology in public health. In addition to his journalism and speaking engagements, and prior to his position with Weird Science, Mr. Sandler was the Manager of DH Services, LLC, an application developer, and the CEO of True Sons Grooming, a subscription service.

How do I contact Carl Forest Sandler?

The corporate mailing address for Mr. Sandler and other Enochian Biosciences executives is 2080 Century Park EastSuite 906, Los Angeles CA, 90067. Enochian Biosciences can also be reached via phone at (305) 918-1980 and via email at [email protected]. Learn More on Carl Forest Sandler's contact information.

Has Carl Forest Sandler been buying or selling shares of Enochian Biosciences?

Carl Forest Sandler has not been actively trading shares of Enochian Biosciences during the past quarter. Most recently, Carl Forest Sandler sold 1,927 shares of the business's stock in a transaction on Tuesday, March 22nd. The shares were sold at an average price of $9.06, for a transaction totalling $17,458.62. Learn More on Carl Forest Sandler's trading history.

Carl Forest Sandler Insider Trading History at Enochian Biosciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/22/2022Sell1,927$9.06$17,458.62View SEC Filing Icon  
2/23/2022Sell6$9.00$54.00View SEC Filing Icon  
2/18/2022Sell6,792$9.03$61,331.76View SEC Filing Icon  
See Full Table

Carl Forest Sandler Buying and Selling Activity at Enochian Biosciences

This chart shows Carl Forest Sandler's buying and selling at Enochian Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Enochian Biosciences Company Overview

Enochian Biosciences logo
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer. The company's product pipeline includes ENOB-HV-01 for autologous HIV curative treatment; ENOB-HV-12, a therapeutic HIV vaccine; and ENOB-HB-01, a gene therapy curative treatment for HBV. It develops ENOB-DC-11, an allogeneic dendritic cell therapeutic vaccine for solid tumors; ENOB-DC-12-XX, allogeneic dendritic cell therapeutic vaccine for other solid tumors; and ENOB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. Enochian Biosciences, Inc. has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was incorporated in 2017 and is headquartered in Los Angeles, California.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $0.61
Low: $0.40
High: $0.79

2 Week Range

Now: N/A

Volume

88,300 shs

Average Volume

137,347 shs

Market Capitalization

$40.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09